GLACIER BANCORP INC (GBCI)

US37637Q1058 - Common Stock

50.45  +0.9 (+1.82%)

After market: 50.45 0 (0%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to GBCI. GBCI was compared to 406 industry peers in the Banks industry. GBCI may be in some trouble as it scores bad on both profitability and health. GBCI is valied quite expensively at the moment, while it does show a decent growth rate.



2

1. Profitability

1.1 Basic Checks

In the past year GBCI was profitable.
In the past year GBCI had a positive cash flow from operations.
In the past 5 years GBCI has always been profitable.
In the past 5 years GBCI always reported a positive cash flow from operatings.

1.2 Ratios

The Return On Assets of GBCI (0.65%) is worse than 61.88% of its industry peers.
GBCI has a Return On Equity of 5.63%. This is in the lower half of the industry: GBCI underperforms 70.05% of its industry peers.
Industry RankSector Rank
ROA 0.65%
ROE 5.63%
ROIC N/A
ROA(3y)1.01%
ROA(5y)1.2%
ROE(3y)9%
ROE(5y)9.86%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

GBCI has a Profit Margin of 22.63%. This is comparable to the rest of the industry: GBCI outperforms 52.72% of its industry peers.
GBCI's Profit Margin has declined in the last couple of years.
The Operating Margin and Gross Margin are not available for GBCI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 22.63%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-7.23%
PM growth 5Y-3.52%
GM growth 3YN/A
GM growth 5YN/A

0

2. Health

2.1 Basic Checks

GBCI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, GBCI has about the same amount of shares outstanding.
The number of shares outstanding for GBCI has been increased compared to 5 years ago.
The debt/assets ratio for GBCI is higher compared to a year ago.

2.2 Solvency

GBCI has a debt to FCF ratio of 7.67. This is a slightly negative value and a sign of low solvency as GBCI would need 7.67 years to pay back of all of its debts.
GBCI's Debt to FCF ratio of 7.67 is on the low side compared to the rest of the industry. GBCI is outperformed by 68.07% of its industry peers.
A Debt/Equity ratio of 0.63 indicates that GBCI is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.63, GBCI is doing worse than 80.94% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 7.67
Altman-Z N/A
ROIC/WACCN/A
WACC7.39%

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

4

3. Growth

3.1 Past

The earnings per share for GBCI have decreased strongly by -27.68% in the last year.
Measured over the past years, GBCI shows a decrease in Earnings Per Share. The EPS has been decreasing by -1.52% on average per year.
Looking at the last year, GBCI shows a decrease in Revenue. The Revenue has decreased by -4.46% in the last year.
GBCI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.95% yearly.
EPS 1Y (TTM)-27.68%
EPS 3Y-10.35%
EPS 5Y-1.52%
EPS Q2Q%-4.26%
Revenue 1Y (TTM)-4.46%
Revenue growth 3Y1.58%
Revenue growth 5Y7.95%
Sales Q2Q%8%

3.2 Future

GBCI is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.15% yearly.
The Revenue is expected to grow by 9.83% on average over the next years. This is quite good.
EPS Next Y-16.1%
EPS Next 2Y11.08%
EPS Next 3Y16.15%
EPS Next 5YN/A
Revenue Next Year1.43%
Revenue Next 2Y8.57%
Revenue Next 3Y9.83%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 31.14, which means the current valuation is very expensive for GBCI.
GBCI's Price/Earnings ratio is rather expensive when compared to the industry. GBCI is more expensive than 84.65% of the companies in the same industry.
When comparing the Price/Earnings ratio of GBCI to the average of the S&P500 Index (27.73), we can say GBCI is valued inline with the index average.
GBCI is valuated rather expensively with a Price/Forward Earnings ratio of 20.34.
Compared to the rest of the industry, the Price/Forward Earnings ratio of GBCI indicates a slightly more expensive valuation: GBCI is more expensive than 76.73% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.83. GBCI is around the same levels.
Industry RankSector Rank
PE 31.14
Fwd PE 20.34

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, GBCI is valued a bit more expensive than 68.81% of the companies in the same industry.
Industry RankSector Rank
P/FCF 21.42
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as GBCI's earnings are expected to grow with 16.15% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y11.08%
EPS Next 3Y16.15%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.39%, GBCI has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 3.02, GBCI has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.24, GBCI has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.39%

5.2 History

The dividend of GBCI has a limited annual growth rate of 4.74%.
GBCI has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)4.74%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

81.20% of the earnings are spent on dividend by GBCI. This is not a sustainable payout ratio.
GBCI's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP81.2%
EPS Next 2Y11.08%
EPS Next 3Y16.15%

GLACIER BANCORP INC

NYSE:GBCI (12/20/2024, 8:14:08 PM)

After market: 50.45 0 (0%)

50.45

+0.9 (+1.82%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)10-24 2024-10-24/amc
Earnings (Next)01-23 2025-01-23/amc
Inst Owners77.63%
Inst Owner Change-0.37%
Ins Owners0.7%
Ins Owner Change-0.96%
Market Cap5.72B
Analysts75
Price Target53.38 (5.81%)
Short Float %4.52%
Short Ratio8.66
Dividend
Industry RankSector Rank
Dividend Yield 2.39%
Dividend Growth(5Y)4.74%
DP81.2%
Div Incr Years0
Div Non Decr Years0
Ex-Date12-10 2024-12-10 (0.33)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)4.69%
Min EPS beat(2)3.62%
Max EPS beat(2)5.76%
EPS beat(4)3
Avg EPS beat(4)3.5%
Min EPS beat(4)-12.98%
Max EPS beat(4)17.58%
EPS beat(8)4
Avg EPS beat(8)0.99%
EPS beat(12)5
Avg EPS beat(12)0.49%
EPS beat(16)9
Avg EPS beat(16)3.02%
Revenue beat(2)1
Avg Revenue beat(2)-0.85%
Min Revenue beat(2)-3.38%
Max Revenue beat(2)1.68%
Revenue beat(4)2
Avg Revenue beat(4)0.56%
Min Revenue beat(4)-4.86%
Max Revenue beat(4)8.79%
Revenue beat(8)4
Avg Revenue beat(8)0.49%
Revenue beat(12)8
Avg Revenue beat(12)4.53%
Revenue beat(16)12
Avg Revenue beat(16)8.58%
PT rev (1m)12.72%
PT rev (3m)18.55%
EPS NQ rev (1m)0.56%
EPS NQ rev (3m)-4.88%
EPS NY rev (1m)0%
EPS NY rev (3m)3.43%
Revenue NQ rev (1m)-0.17%
Revenue NQ rev (3m)-3.64%
Revenue NY rev (1m)-0.16%
Revenue NY rev (3m)-2.99%
Valuation
Industry RankSector Rank
PE 31.14
Fwd PE 20.34
P/S 7.09
P/FCF 21.42
P/OCF 18.62
P/B 1.76
P/tB 2.67
EV/EBITDA N/A
EPS(TTM)1.62
EY3.21%
EPS(NY)2.48
Fwd EY4.92%
FCF(TTM)2.36
FCFY4.67%
OCF(TTM)2.71
OCFY5.37%
SpS7.12
BVpS28.62
TBVpS18.86
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.65%
ROE 5.63%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 22.63%
GM N/A
FCFM 33.09%
ROA(3y)1.01%
ROA(5y)1.2%
ROE(3y)9%
ROE(5y)9.86%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-7.23%
PM growth 5Y-3.52%
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 7.67
Debt/EBITDA N/A
Cap/Depr 99.7%
Cap/Sales 4.97%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 146.21%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score4
WACC7.39%
ROIC/WACCN/A
Cap/Depr(3y)75.18%
Cap/Depr(5y)64.81%
Cap/Sales(3y)3.27%
Cap/Sales(5y)2.78%
Profit Quality(3y)182.55%
Profit Quality(5y)142.85%
High Growth Momentum
Growth
EPS 1Y (TTM)-27.68%
EPS 3Y-10.35%
EPS 5Y-1.52%
EPS Q2Q%-4.26%
EPS Next Y-16.1%
EPS Next 2Y11.08%
EPS Next 3Y16.15%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.46%
Revenue growth 3Y1.58%
Revenue growth 5Y7.95%
Sales Q2Q%8%
Revenue Next Year1.43%
Revenue Next 2Y8.57%
Revenue Next 3Y9.83%
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-44.73%
FCF growth 3Y36.42%
FCF growth 5Y11.49%
OCF growth 1Y-39.21%
OCF growth 3Y38.25%
OCF growth 5Y12.27%